Additional file 1 of Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer’s mouse model SankarSitara Infante-GarciaCarmen WeinstockLaura Ramos-RodriguezJuan Hierro-BujalanceCarmen Fernandez-PonceCecilia WoodLevi Garcia-AllozaMonica 2020 Additional file 1: Figure S1. Metabolic assessment, amyloid pathology and microglia burden are altered in mixed models of metabolic disease and AD. Figure S2. APP/PS1-STZ pathology upregulates a profile of cytokines compared to wild-type control. Figure S3. Individual cytokines measured for APP/PS1, STZ, and APP/PS1-STZ groups. Figure S4. APP/PS1xdbdb pathology upregulates a profile of cytokines compared to wild-type controls. Figure S5. Individual cytokines measured for APP/PS1, dbdb, and APP/PS1xdbdb groups. Figure S6. APP/PS1-HFD pathology upregulates a profile of cytokines compared to wild-type controls. Figure S7. Individual cytokines measured for APP/PS1, HFD, and APP/PS1-HFD groups.